Ballal Rahul D.

Enliven Therapeutics, Inc. · Director

Ballal Rahul D. is listed in public filings as director. This Ballal Rahul D. insider trading page organizes Form 4 disclosures, reported purchases and sales, transaction dates, share amounts, related issuers, and historical insider activity so readers can review the person's public trading record in one place. Companies and tickers connected to this insider trading profile include Enliven Therapeutics, Inc. (ELVN), and Agios Pharmaceuticals, Inc. - Common Stock (AGIO) (AGIO). Investors use Ballal Rahul D.'s insider trading disclosures to study buying and selling patterns, position changes, company-specific activity, and the source evidence behind each reported transaction.

Latest Actions

CompanyHolding ValueLast TransactionAmountTransaction PriceCurrent Price
Enliven Therapeutics, Inc.ELVN$465k17.1k sharesGrant / ExerciseFeb 12, 2026$465.1K17.1k shares$27.16--

Insider Trades History

CompanyHolding ValueLast TransactionAmountTransaction PriceCurrent Price
Agios Pharmaceuticals, Inc. - Common Stock (AGIO)AGIO--2.3k sharesGrant / ExerciseAug 11, 2025Disclosure amount unavailable2.3k shares----
Agios Pharmaceuticals, Inc. - Common Stock (AGIO)AGIO--2.1k sharesGrant / ExerciseJun 20, 2025Disclosure amount unavailable2.1k shares----
Agios Pharmaceuticals, Inc. - Common Stock (AGIO)AGIO$560k15.8k sharesGrant / ExerciseJun 18, 2025$559.8K15.8k shares$35.50--
Agios Pharmaceuticals, Inc. - Common Stock (AGIO)AGIO--2.8k sharesGrant / ExerciseJun 18, 2025Disclosure amount unavailable2.8k shares----
Enliven Therapeutics, Inc.ELVN$460k20.5k sharesGrant / ExerciseFeb 6, 2025$460.4K20.5k shares$22.47--
Agios Pharmaceuticals, Inc. - Common Stock (AGIO)AGIO$556k9.5k sharesSellNov 8, 2024$288.7K4.9k shares$58.57--
Agios Pharmaceuticals, Inc. - Common Stock (AGIO)AGIO$466k17.9k sharesGrant / ExerciseNov 8, 2024$259.9K10k shares$25.99--
Agios Pharmaceuticals, Inc. - Common Stock (AGIO)AGIO$825k14.4k sharesSellNov 8, 2024$204.4K3.6k shares$57.24--
Agios Pharmaceuticals, Inc. - Common Stock (AGIO)AGIO$473k8k sharesSellNov 8, 2024$88.8K1.5k shares$59.21--
Agios Pharmaceuticals, Inc. - Common Stock (AGIO)AGIO$526k9.9k sharesSellNov 7, 2024$433.6K8.1k shares$53.32--
Agios Pharmaceuticals, Inc. - Common Stock (AGIO)AGIO$726k27.9k sharesGrant / ExerciseNov 7, 2024$259.9K10k shares$25.99--
Agios Pharmaceuticals, Inc. - Common Stock (AGIO)AGIO$435k8k sharesSellNov 7, 2024$101.6K1.9k shares$54.41--
Enliven Therapeutics, Inc.ELVN$629k22.3k sharesSellOct 8, 2024$293.6K10.4k shares$28.17--
Enliven Therapeutics, Inc.ELVN$564k28.7k sharesGrant / ExerciseOct 8, 2024$124.3K6.3k shares$19.68--
Enliven Therapeutics, Inc.ELVN$68k12.3k sharesGrant / ExerciseOct 8, 2024$22.7K4.1k shares$5.52--